Korro Bio, Inc.
KRRO
$14.48
$0.372.62%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/15/2025
-
MarketBeat
5/15/2025
-
Tickeron - Stocks
5/15/2025
-
Zolmax
5/15/2025
-
MarketBeat
5/14/2025
-
Globe Newswire
5/13/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
The Fly
5/13/2025
-
Ticker Report
5/13/2025
-
MarketBeat
5/13/2025
-
MarketBeat
5/11/2025
-
MarketBeat
5/9/2025
-
Yahoo! Finance: News
5/8/2025
-
GuruFocus
5/8/2025
-
MarketBeat
5/8/2025
-
The Fly
5/8/2025
-
Ticker Report
5/8/2025
-
GuruFocus
5/8/2025
-
TipRanks Financial Blog
5/8/2025
-
GuruFocus
5/8/2025
-
TipRanks Financial Blog
5/8/2025
-
The Fly
5/8/2025
-
FierceBiotech.com - Biotech
5/8/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 7, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 468 1999
Address
One Kendall Square
Building 600-700 - Suite 6-401
Cambridge, MA 02139
Building 600-700 - Suite 6-401
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent...
more